Quoin Pharmaceuticals Ltd (NASDAQ:QNRX)
| 1.70 Delayed Data As of Dec 02 |  -0.03 / -1.73%Today’s Change | 1.57 Today|||52-Week Range 64.38 | -92.53% Year-to-Date |
Latest QNRX News | Press Releases
No recent news for Quoin Pharmaceuticals Ltd.
Today’s Trading
| Previous close | 1.73 |
| Today’s open | 1.71 |
| Day’s range | 1.71 - 1.72 |
| Volume | 879 |
| Average volume (3 months) | 1,988,202 |
| Market cap | $8.9M |
Data as of 3:59pm ET, 12/02/2022
Growth & Valuation
| Earnings growth (last year) | +81.12% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.87 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NEPTNeptune Wellness Sol... | -0.04 | -5.47% |
| BLCMBellicum Pharmaceuti... | +0.03 | +3.00% |
| ATHXAthersys Inc | +0.02 | +3.38% |
| HMTXFHemostemix Inc | -0.01 | -7.23% |
Data as of 3:55pm ET, 12/02/2022
Financials
| Next reporting date | March 27, 2023 |
| EPS forecast (this quarter) | -$0.54 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$21.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kefar Sava, Tel Aviv |
Forecasts
